期刊文献+

感染性发热患者临床特点及其病原菌耐药性分析 被引量:3

Clinical Feature and Bacterial Resistance among Patients with Infectious Fever:An analysis
下载PDF
导出
摘要 目的研究感染性发热患者的临床特点及其病原菌耐药情况。方法回顾性分析70例发热患者的临床特点,将病原菌株进行耐药性分析。结果从所送标本分离出致病菌70株,G+球菌40株(57.1%),其中金黄色葡萄球菌8株,凝固酶阴性葡萄球菌(CNS)32株;G-杆菌30株(42.9%),以沙门菌属及大肠埃希菌为主;药敏显示,53.1%的CNS对苯唑西林耐药,5株产ESBLs的菌株仅对碳青酶烯类及阿米卡星敏感。结论感染科病房多以G+球菌为主,产ESBLs的G-杆菌易致多重耐药,因此须合理选用抗菌药物,减少耐药菌株产生。 OBJECTIVE To study the clinical feature among patients with infectious fever and the antimicrobial resistance of infection pathogens. METHODS A retrospective analysis was carried out among 70 cases during recent 3 years. RESULTS The 70 strains of pathogens were isolated from blood and/or bone marrow cultures of 70 patients with infectious fever, 40 strains (57.1%) were Gram-positive cocci, in which 8 strains were Staphylococcus aureus, and 32 strains were coagulase negative staphylococci (CONS) ; 30 strains (42.9%) were Gram-negative bacilli,of which the Salmonella and Escherichia coli were the main microorganisms, 53. 1% of CONS were resistant to oxacillin. There were 5 strains of Gram-negative bacilli that were suspected to produce extended spectrum β-1actamases (ESBLs), which were resistant to multiple antibiotics, the most active agent against these Gram-negative bacilli with ESBLs was imipenem. CONCLUSIONS The bacteria are mainly Gram- positive cocci for the patients with infectious fever in the infectious wards. The Gram-negative bacilli with ESBLs show more multi-drug resistance, we should rationally select antibiotics and decrease the occurrence of drug resistant strains.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第6期749-751,共3页 Chinese Journal of Nosocomiology
关键词 感染性发热 临床特点 耐药性 Infectious fever Clinical feature Bacterial resistance
  • 相关文献

参考文献4

二级参考文献18

  • 1辜依海,罗燕萍,张文莉,张军民.耐亚胺培南铜绿假单胞菌的耐药性分析及金属β-内酰胺酶检测[J].中华医院感染学杂志,2005,15(3):339-341. 被引量:47
  • 2侯林浦.C—反应性蛋白及其临床检测的意义[J].临床检验杂志,1986,4:96-96.
  • 3National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing. 11 th inform suppl. M2-M7 and M7-M5. National Committee for Clinical Laboratory Standards,Wayne, PA, 2001
  • 4Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am, 1997, 11:479
  • 5Fridkin SK, Hill HA, Volkva NV et al. Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U. S. Hospitals. Emerging Infectious Diseases, 2002, 8(7): 697
  • 6National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing;Ninth Informational Supplement,NCCLS documents M100-S9[S].Pennsylvania:NCCLS,1999.1-103.
  • 7Levy S.Multidrug resistance-a sign of the times[J].N Engl J Med,1998,338:1376-1378.
  • 8Witte W.Antibiotic resistance in Gram-positive bacteria:epidemiological aspects[J].J Antimicrob Chemother,1999,44Topic A:1-9.
  • 9Andrews J,Ashby J,Jevons G,et al.Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997[J].J Antimicrob Chemother,1999,43:689-698.
  • 10Schmitz FJ,Verhoef J,Fluif AC,et al.Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY Surveillance Propramme[J].J Antimicrob Chemother,1999,41:783-792.

共引文献82

同被引文献52

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部